Torrent Pharmaceuticals is moving forward with its strategic plan to acquire a 72.39% stake in JB Chemicals and Pharmaceuticals Ltd. The two-phase acquisition represents one of the largest consolidation moves in the Indian pharmaceutical sector.
The deal underscores the ongoing trend of consolidation in India’s pharma industry, as companies seek to enhance their product portfolios, strengthen distribution networks, and achieve economies of scale in manufacturing.
JB Chemicals brings a strong portfolio of branded generics and over-the-counter products, particularly in the gastroenterology and cardiology segments. The acquisition is expected to complement Torrent’s existing therapeutic focus areas.
The pharmaceutical sector has been witnessing increased M&A activity as companies position themselves for growth in both domestic and export markets. Indian pharma companies are also eyeing acquisitions abroad to expand their global footprint.
Analysts view the consolidation as positive for the sector, noting that larger, more diversified companies are better positioned to invest in R&D, navigate regulatory requirements, and compete in the global generic drug market.
